UNSPSC 51142559: Pergolide mesilate or mesylate

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula C19H26N2S.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 55B9HQY616, chemically known as ergoline, 8-((methylthio)methyl)-6-propyl-, monomethanesulfonate, (8beta)- but more generally known as pergolide mesilate, which bears US NIH Compound Identifier 47812. European Medicines Agency schedules Pergolide mesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03709MIG.

UNSPSC 51142559 Pergolide mesilate or mesylate is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The single available opportunity—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with a due date of July 26, 2023—solicits naloxone and safe drug deactivation systems for community health initiatives, not pergolide mesilate, a dopamine agonist pharmaceutical typically used in Parkinson's disease treatment. The mismatch between the code's nominal scope and the actual procurement suggests a coding classification error in the source record.

No recent state and local contract opportunities directly align with pergolide mesilate procurement. The single tagged opportunity addresses naloxone distribution and drug deactivation equipment, which falls outside the pharmaceutical scope of the code. This code shows little relevant recent activity in state and local procurement records.